lundi 18 mai 2015

Onco Actu du 18 mai 2015

Voir aussi le "Spécial ASCO" du jour

1. Biologie

Single Cells Analyzed at Unprecedented Scale [MIT Technology Review]

3.1 Tabac

Financial incentives could help smokers quit says US study [Cancer Research UK]

Keeping Our Kids Safe From E-cigarettes [CANCER RESEARCH Catalyst]

Want to quit smoking? Penalties more effective than rewards, new study finds [The Guardian]

Incentive Programs to Urge Smokers to Quit: Lessons from Behavioral Science [Now@NEJM]

To make smokers healthy, it helps to make them wealthy, study finds [LA Times]

3.3 Prévention - Vaccins

HPV Vaccine Compliance [Science-Based Medicine]

4.1 Dép., diag. & prono. - Prostate

Oncotype DX ® Prostate Cancer Test Improves Risk Assessment for One in Four Men and Reduces Overall Healthcare Costs [Genomic Health]

Myriad Validates Active Surveillance Threshold With Prolaris(R) for Men With Prostate Cancer [Myriad]

4.10 Dép., diag. & prono. - Poumon

Veracyte lung cancer test could help avoid some risky biopsies [Reuters]

4.2 Dép., diag. & prono. - Génome

Mary-Claire King on Inherited Breast/Ovarian Cancer [MassGenomics]

Genomics-Enabled Learning Health Care Systems: Gathering and Using Genomic Information to Improve Patient Care and Research: Workshop Summary [The National Academies Press]

How DNA sequencing is transforming the hunt for new drugs [Reuters]

4.9 Dép., diag. & prono. - Sein

Breast Cancer Screening: Let Evidence Trump Fear [Health Affairs]

5. Traitements

Refractory Metastatic Colon Cancer [Now@NEJM]

Scientists identify a new strategy to kill cancer cells [The Institute of Cancer Research]

New drug combination extends survival of patients with metastatic colorectal cancer [Dana-Farber Cancer Institute]

Protein FGL2 May Have Potential as Therapy Target for Brain Cancer [MD Anderson Cancer Center]

5.12 Immunothérapies

Advancing Immunotherapy for All Cancers [Cancer Research Institute Blog]

The Science of PD-1 and Immunotherapy [Dana-Farber Cancer Institute]

5.2 Pharma

One of Takeda's big cancer bets flops in a Phase III lymphoma trial [FierceBiotech]

5.2.1 Pharma - Partenariats

Sorrento Sells Cynviloq for $1.3B [GEN]

Soon-Shiong bets $90M on Sorrento's next-gen Abraxane with $1.2B on the line [FierceBiotech]

5.4 Traitements - Economie

Non-Tyrosine Kinase Inhibitors in Oncology, 2015-2025 [Report Buyer]

6. Lutte contre les cancers

In praise of academic cancer treatment studies [The Cancer Blog]

6.10 Politiques

America Needs Bolder Science And The 21st Century Cures Act Should Empower It [Forbes]

The 21st Century Cures Act Evolves and Moves into Mark-Up [FDA Law Blog]

The 21st Century Cures Act and Drug Company Promotion of Real-World Data [Health Affairs]

Election 2015: What does the result mean for cancer? [Cancer Research UK]

6.11 Patients

'Death is hard. Living with cancer can be harder' – in pictures [The Guardian]

A moment that changed me – my first chemotherapy session [The Guardian]

What I’m really thinking: the mother with cancer [The Guardian]

6.8 Communication

The Fault In Our Stars: When Celebrity Health Advice Conflicts With Our Science [Dr Len]

6.9 Controverses

Doctors issue warning about overtreating patients [NHS Choices]